The latest Investing Matters Podcast episode with London Stock Exchange Group's Chris Mayo has just been released. Listen here.
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
Better if I had put money in Eli Lilly: results of Alzheimer's study.
There good news all over TV last 3 days .
But share price was higher last week , share price moving on such a good news RNS ?
The two hedge funds control the price here.
Redmile Group, LLC ,
Vulpes Investment Management Private Limited
Just seen on chart 8.75p on 17/7/23.
Still a few of my other boats are cumming in .
Corrected: Roche is not moving forward with SQZ, sending the biotech into strategic review
Lei Lei Wu
News Reporter
This story was corrected to note that Roche has elected not to take its option on SQZ’s program. A previous version said that Roche and SQZ had ended their partnership.
Roche is walking away from its collaboration on SQZ Biotechnologies’ clinical program.
Roche decided not to license and develop SQZ’s antigen presenting cells (APCs) that are designed to spark killer T cells to go after HPV16-positive cancers, the biotech announced Tuesday morning. The program is SQZ’s only APC in the clinic, which it is testing in a Phase I/II study in patients with head and neck, cervical, anal, vulvar, or penile cancers.
Should that heading be.......... Why IS Scancell share price falling ?.
In hindsight I would of been wiser to put the money into hVIVO on 12 July 2023 .
Same healthcare sector this keeps going down , HVO up 25% since then.
And doubled over last 9 months.
New low since September 2020 when share increased from 7p to 16p, yesterday back down to 8.15p.
I see others posters now not so sure about the "What incredible news for Trish" posts , December of last year.
The gamble last top up on 12th July at 10.5p now ahead after today's 30% one day gain now 13p
It was 8.15p two weeks ago tomorrow.
AIM.
Mentioning that I bought a main market share that fell 30% today .
Up 5.45% spread 5.43%
After moving up a little yesterday to 16p , went 17p to 1pm before falling back.
Great news in RNS today but, as an ignorant LTH , I am also much more optimistic about the wimpy 90% below from the RNS "Based upon the first 11 patients there is a greater than 90% probability that the second phase will also be successful."
Fallen back to 13.5p since my last post.
TW on Share Prophets asked this question on 20/10/23 , do not know what his answer was .
Scancell: Audit Issues Mean Further Delayed Results But Is There Something Else Of (Going) Concern?
AIM-listed biotech Scancell (SCLP) ‘fessed up this morning that its full year results to April would be further delayed, originally promised for Thursday of last week and then 24th October. Now we are told they will be released as soon as the auditor completes their final processes – in other words, no fixed date. Is there anything to worry about here?
Ripley,
Did you read the latest RNS? There is an issue on the auditor side, not with Scancell’s accounts.
“Scancell's Board has been advised that the audit is substantially complete and has not been advised of any material audit issues.”
Questions over going concern would constitute ‘material audit issues’.
Strange he doesn't post 'risen from 13 to 13.5 on no news yesterday - what's behind the rise?'
Mind you, with a TW link any credibility goes straight out of the window.
Just noticed placing last Thursday for 11p 6m raise , small OO , they are in acc this morning.
Now everyone should know there worth .
What is acc ? Do you have a link
Large buy gone through on AQUIS.
SCLP.GB.PL
Chester.
Chester et al...perhaps the placing price will act as the floor and organisations now know thay with funding sorted ...they will need to buy a position on the open market. Was the increased placing enough to satisfy their appetite or is there still a latent demand. Fingers crossed we get a well deserved re-rate !
Definitely some interesting SP moves. I would have expected it to hover around the OO price but it looks like we’re heading up.
We're always in hope that the market finally realises the potential of Scancell.
Maybe the oversubscribed capital raise is the catalyst.
Liking the 100000 clips going through : )
Notice KonarA has not posted after the placing at 11p
Good job I took some off the table 13/4/23 at 20p
Maybe he bought some on 4/9/23 at the 8.15p low.
Ripley - Konar seems to know what he's doing.
You'll be well placed now, having sold some at 20p, to put some more back on the table and that's great. GL
TorquayFan I am sure all the ramp group know what they are doing .
Must have a look back at the trish thread and note the names .
Konar
"Why are the little little ramp group not buying when they mocked me for doubting the trish stuff and warning others " .
His response
Its right there in the RNS you utter clown ( Not a reference to the placing RNS )
You "doubted the Trish stuff"
The clinical data for that patient was included in the clinical update RNS.
Case closed.
You "doubted the Trish stuff"
The clinical data for that patient was included in the clinical update RNS.
Case closed.